Royal Bank of Canada’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-416
Closed -$2K 8331
2021
Q4
$2K Sell
416
-74
-15% -$314 ﹤0.01% 7464
2021
Q3
$2K Hold
490
﹤0.01% 7427
2021
Q2
$2K Sell
490
-193
-28% -$1.01K ﹤0.01% 7289
2021
Q1
$3K Buy
683
+71
+12% +$308 ﹤0.01% 7206
2020
Q4
$2K Buy
612
+6
+1% +$23 ﹤0.01% 6910
2020
Q3
$3K Sell
606
-23
-4% -$80 ﹤0.01% 6281
2020
Q2
$1K Buy
629
+291
+86% +$845 ﹤0.01% 6570
2020
Q1
$1K Buy
338
+43
+15% +$188 ﹤0.01% 6594
2019
Q4
$2K Buy
295
+175
+146% +$836 ﹤0.01% 6612
2019
Q3
$1K Hold
120
﹤0.01% 6622
2019
Q2
$1K Hold
120
﹤0.01% 6804
2019
Q1
$1K Buy
+120
New +$793 ﹤0.01% 6745
2018
Q4
Sell
-128
Closed -$1K 7545
2018
Q3
$1K Buy
+128
New +$961 ﹤0.01% 6662
2015
Q3
Sell
-36,500
Closed -$225K 6903
2015
Q2
$225K Sell
36,500
-18,612
-34% -$114K ﹤0.01% 4280
2015
Q1
$282K Sell
55,112
-11,302
-17% -$55.6K ﹤0.01% 3978
2014
Q4
$301K Sell
66,414
-5,123
-7% -$24.3K ﹤0.01% 4033
2014
Q3
$350K Buy
71,537
+24,384
+52% +$118K ﹤0.01% 3795
2014
Q2
$260K Buy
47,153
+47,084
+68,238% +$211K ﹤0.01% 3977
2014
Q1
$0 Buy
+69
New +$280 ﹤0.01% 6277

Other funds holding CO

Royal Bank of Canada's CO Position: Q1 2022 in Review

Royal Bank of Canada sold out of Global Cord Blood Corporation (CO) in Q1 2022, closing a stake of 416 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in CO in Q1 2014 and held it in 19 quarters. The position peaked at $350K in Q3 2014. 29 funds tracked by Wall St. Rank hold CO as of Q1 2022.

  • Royal Bank of Canada reported no remaining Global Cord Blood Corporation position as of Q1 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 416 Global Cord Blood Corporation shares in Q1 2022, an estimated $2K.
  • Royal Bank of Canada first reported a position in Global Cord Blood Corporation in Q1 2014 and held it in 19 quarters.
  • Royal Bank of Canada's Global Cord Blood Corporation position peaked at $350K in Q3 2014.
  • 29 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2022.

Based on Royal Bank of Canada's 13F filing for Q1 2022, filed 16 May 2022.